2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association
- PMID: 20974767
- DOI: 10.1093/europace/euq392
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association
Similar articles
-
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.Eur Heart J. 2010 Nov;31(21):2677-87. doi: 10.1093/eurheartj/ehq337. Epub 2010 Aug 27. Eur Heart J. 2010. PMID: 20801924 No abstract available.
-
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.Eur J Heart Fail. 2010 Nov;12(11):1143-53. doi: 10.1093/eurjhf/hfq192. Eur J Heart Fail. 2010. PMID: 20965877 No abstract available.
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19. Eur Heart J. 2012. PMID: 22611136 No abstract available.
-
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).Eur J Heart Fail. 2024 Feb;26(2):483-501. doi: 10.1002/ejhf.3150. Epub 2024 Jan 25. Eur J Heart Fail. 2024. PMID: 38269474 Review.
-
Implantable Cardiac Defibrillator or Cardiac Resynchronization Therapy in Severe Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Am J Ther. 2020 Nov/Dec;27(6):e652-e657. doi: 10.1097/MJT.0000000000001028. Am J Ther. 2020. PMID: 32427620 No abstract available.
Cited by
-
Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study.Front Pharmacol. 2018 Oct 25;9:1212. doi: 10.3389/fphar.2018.01212. eCollection 2018. Front Pharmacol. 2018. PMID: 30459608 Free PMC article.
-
Rhythm Control in Heart Failure Patients with Atrial Fibrillation.Arrhythm Electrophysiol Rev. 2020 Nov;9(3):161-166. doi: 10.15420/aer.2020.23. Arrhythm Electrophysiol Rev. 2020. PMID: 33240512 Free PMC article. Review.
-
Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.Clin Cardiol. 2014 Nov;37(11):707-15. doi: 10.1002/clc.22312. Epub 2014 Aug 25. Clin Cardiol. 2014. PMID: 25156448 Free PMC article.
-
First clinical evaluation of an atrial haemodynamic sensor lead for automatic optimization of cardiac resynchronization therapy.Europace. 2016 May;18(5):755-61. doi: 10.1093/europace/euv114. Epub 2015 May 14. Europace. 2016. PMID: 25976907 Free PMC article.
-
Response to cardiac resynchronization therapy: the muscular metabolic pathway.Cardiol Res Pract. 2010 Dec 20;2011:830279. doi: 10.4061/2011/830279. Cardiol Res Pract. 2010. PMID: 21197405 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical